
News|Articles|August 1, 2009
First-time generic drug approval, August 2009
Generic drug approved by FDA (through August 2009): ethinyl estradiol/norgestimate tablets
Advertisement
Ethinyl estradiol/norgestimate tablets, 0.025/0.18 mg, 0.025/0.215 mg, and 0.025/0.25 mg (trade name, Tri-Lo Sprintec) (equiv to Ortho Tri-Cyclen Lo)
TEVA
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
2
Antipsychotics are effective but can also lead to weight gain, impacting treatment adherence
3
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
4
Zabopegdutide shows 62.5% MASH resolution rate at 48 weeks
5


























